フォロー
Saulo Cabral Bourguignon
Saulo Cabral Bourguignon
その他の名前Saulo C Bourguignon, Bourguignon SC, Saulo Bourguignon
Professor Titular de Biologia Celular da UFF
確認したメール アドレス: id.uff.br - ホームページ
タイトル
引用先
引用先
Leishmaniasis treatment—a challenge that remains: a review
DO Santos, CER Coutinho, MF Madeira, CG Bottino, RT Vieira, ...
Parasitology research 103, 1-10, 2008
4172008
Trypanocidal agents with low cytotoxicity to mammalian cell line: a comparison of the theoretical and biological features of lapachone derivatives
VF Ferreira, A Jorqueira, AMT Souza, MN da Silva, MCBV de Souza, ...
Bioorganic & medicinal chemistry 14 (16), 5459-5466, 2006
1102006
Leishmania amazonensis: early proteinase activities during promastigote–amastigote differentiation in vitro
CR Alves, S Corte-Real, SC Bourguignon, CS Chaves, EMB Saraiva
Experimental parasitology 109 (1), 38-48, 2005
852005
Potency evaluation of antivenoms in Brazil: the national control laboratory experience between 2000 and 2006
HP Araujo, SC Bourguignon, MAA Boller, A Dias, EPR Lucas, IC Santos, ...
Toxicon 51 (4), 502-514, 2008
732008
Oxyrane derivative of α-lapachone is potent growth inhibitor of Trypanosoma cruzi epimastigote forms
A Jorqueira, RM Gouvêa, VF Ferreira, MN da Silva, MCBV de Souza, ...
Parasitology research 99, 429-433, 2006
562006
BJ-48, a novel thrombin-like enzyme from the Bothrops jararacussu venom with high selectivity for Arg over Lys in P1: role of N-glycosylation in thermostability and active site …
FP Silva-Junior, HLM Guedes, LC Garvey, AS Aguiar, SC Bourguignon, ...
Toxicon 50 (1), 18-31, 2007
542007
Efficacy of 2-hydroxy-3-phenylsulfanylmethyl-[1, 4]-naphthoquinone derivatives against different Trypanosoma cruzi discrete type units: Identification of a promising hit compound
LS Lara, CS Moreira, CM Calvet, GC Lechuga, RS Souza, ...
European Journal of Medicinal Chemistry 144, 572-581, 2018
472018
Epoxy-α-Lapachone Has In Vitro and In Vivo Anti-Leishmania (Leishmania) amazonensis Effects and Inhibits Serine Proteinase Activity in This Parasite
F Souza-Silva, SC Bourguignon, BAS Pereira, LMC Côrtes, ...
Antimicrobial Agents and Chemotherapy 59 (4), 1910-1918, 2015
452015
New oxirane derivatives of 1, 4-naphthoquinones and their evaluation against T. cruzi epimastigote forms
PF Carneiro, SB do Nascimento, AV Pinto, FR Maria do Carmo, ...
Bioorganic & medicinal chemistry 20 (16), 4995-5000, 2012
452012
Trypanosoma cruzi: Insights into naphthoquinone effects on growth and proteinase activity
SC Bourguignon, DFB Cavalcanti, AMT de Souza, HC Castro, ...
Experimental parasitology 127 (1), 160-166, 2011
402011
Trypanosoma cruzi: in vitro activity of Epoxy-α-Lap, a derivative of α-lapachone, on trypomastigote and amastigote forms
SC Bourguignon, HC Castro, DO Santos, CR Alves, VF Ferreira, IL Gama, ...
Experimental Parasitology 122 (2), 91-96, 2009
372009
Evidences for leishmanicidal activity of the naphthoquinone derivative epoxy-α-lapachone
F Souza-Silva, SB do Nascimento, SC Bourguignon, BAS Pereira, ...
Experimental Parasitology 147, 81-84, 2014
362014
Localization of lectin-binding sites on the surface of Trypanosoma cruzi grown in chemically defined conditions
SC Bourguignon, W de Souza, T Souto-Padron
Histochemistry and Cell Biology 110, 527-534, 1998
361998
Detrimental effect of nitric oxide on Trypanosoma cruzi and Leishmania major like cells
SC Bourguignon, CR Alves, S Giovanni-De-Simone
Acta tropica 66 (2), 109-118, 1997
321997
Interaction of Mycobacterium leprae with the HaCaT human keratinocyte cell line: new frontiers in the cellular immunology of leprosy
ECD Lyrio, IC Campos‐Souza, LCD Corrêa, GC Lechuga, M Verícimo, ...
Experimental dermatology 24 (7), 536-542, 2015
302015
Expression of B7‐1 costimulatory molecules in patients with multibacillary leprosy and reactional states
DO Santos, HC Castro, SC Bourguignon, OM Bastos, CR Rodrigues, ...
Clinical and experimental dermatology 32 (1), 75-80, 2007
302007
The combination therapy of meglumine antimoniate and oxiranes (epoxy-α-lapachone and epoxymethyl-lawsone) enhance the leishmanicidal effect in mice infected by Leishmania …
LF Gonçalves-Oliveira, F Souza-Silva, LM de Castro Côrtes, LB Veloso, ...
International Journal for Parasitology: Drugs and Drug Resistance 10, 101-108, 2019
272019
Biological aspects of the Trypanosoma cruzi (Dm28c clone) intermediate form, between epimastigote and trypomastigote, obtained in modified liver infusion tryptose (LIT) medium
SC Bourguignon, CB Mello, DO Santos, MS Gonzalez, T Souto-Padron
Acta tropica 98 (1), 103-109, 2006
252006
Interactions between 4-aminoquinoline and heme: Promising mechanism against Trypanosoma cruzi
GC Lechuga, JC Borges, CM Calvet, HP de Araújo, AA Zuma, ...
International Journal for Parasitology: Drugs and Drug Resistance 6 (3), 154-164, 2016
242016
Infection of Mouse Dermal Fibroblasts by the Monoxenous Trypanosomatid Protozoa Crithidia deanei and Herpetomonas roitmani
DO Santos, SC Bourguignon, HC Castro, JS Silva, LS Franco, ...
Journal of Eukaryotic Microbiology 51 (5), 570-574, 2004
242004
現在システムで処理を実行できません。しばらくしてからもう一度お試しください。
論文 1–20